Corey M. Priest alias The Root-Cause Rack
moving supplement units at Overland Park’s Functional Medicine Clinic
Website · in2greatkc.com
Practice location
6806 W 83rd St
Overland Park, KS 66204
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 44 health claims, 7 run counter to or conflict with the published evidence, and 37 were not independently checked.
- Primary persuasion tactic: Cancer as a systems problem to be managed by the clinic.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Corey Priest has built a very efficient little cathedral to the gospel of ‘root cause,’ where every mystery symptom apparently justifies a longer visit, a bigger lab panel, and a more personalized protocol. The page is less a clinic brochure than a conversion funnel with a stethoscope costume: serious disease labels go in, high-margin functional interventions come out.
High grift signals
Score breakdown
Direct answer
Corey M. Priest is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. §65-2871 (Kansas Healing Arts Act)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Cancer Support, Autoimmune Conditions, Leaky Gut & Digestive Disorders, Lyme Disease, and Mold Toxicity, conditions that belong with infectious-disease physicians, rheumatologists, and oncologists. Those same pages route patients toward supplements, lab panels, and paid programs that Corey M. Priest profits from.
Key findings
- Fear Mongering: The clinic presents cancer as one of the conditions it can address with its own protocols and testing, which can pull patients away from oncology-led care and toward a profit center built on fear and uncertainty.see section ↓
- Claim "Cancer Support": mixed in the medical literature.see section ↓
- Claim "Autoimmune conditions": mixed in the medical literature.see section ↓
- NPI registry confirms Corey Priest as Chiropractor (DC) in Kansas (NPI 1518001098).see section ↓
- Corey M. Priest shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Corey M. Priest is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. §65-2871 (Kansas Healing Arts Act)), these advertised activities appear outside Corey M. Priest's license (including conditions they merely list as ones they treat): Cancer Support, Autoimmune Conditions, CIRS (Chronic…see section ↓
- 24 of 24 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
24 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Cancer Support.
Cancer Support
- Supports
- The indexed systematic review and meta-analysis on primary G‑CSF prophylaxis for adjuvant TC or FEC‑D chemotherapy in breast cancer provides high‑quality evidence that colony‑stimulating factor (CSF) support reduces chemotherapy‑induced neutropenia and febrile neutropenia, thereby improving the safety and tolerance of curative‑intent regimens. [1][2][3][4][5][6][7][8][9][10] Major guidelines and consensus papers accessed via academic search similarly recommend CSF prophylaxis as a key component of supportive care in patients receiving myelosuppressive chemotherapy at high (≥20%) or intermediate (10–20%) risk of febrile neutropenia, especially when maintaining dose intensity is important for cancer outcomes. Dose‑dense adjuvant chemotherapy guidelines in breast cancer explicitly incorporate G‑CSF support to maintain dose intensity and survival benefit, underscoring that supportive care measures (such as G‑CSF) are integral to modern cancer treatment rather than optional extras. Canadian and European supportive care recommendations classify interventions such as G‑CSF, antiemetics, pain management, infection prophylaxis, nutritional and psychosocial support as part of comprehensive cancer supportive and palliative care, aimed at helping patients tolerate treatment and maintain quality of life.
- Contradicts
- None of the indexed high‑quality studies or guidelines claim that supportive care alone can cure cancer; rather, they show that supportive measures (for example, prophylactic G‑CSF) reduce toxicity, hospitalizations, and treatment interruptions but do not replace definitive anticancer therapies. [1][3][4][5][6][7][8][9][10] The multi‑institutional analysis of chemotherapy versus best supportive care in advanced biliary tract carcinoma shows that best supportive care by itself is inferior to active chemotherapy for overall survival in patients with good performance status, indicating that supportive care without disease‑directed therapy is not sufficient when effective systemic treatments exist. [2] Guidelines on dose‑dense chemotherapy and CSF use emphasize that supportive care is used to enable patients to receive optimal anticancer regimens, not as a stand‑alone anticancer strategy. Overall, available evidence contradicts any implication that “cancer support” products or strategies, if they are presented as alternatives to standard oncologic treatment, have proven curative or disease‑modifying effects comparable to chemotherapy, targeted therapy, immunotherapy, or radiotherapy.
- Mainstream view
- Mainstream oncology defines cancer supportive care as evidence‑based interventions that help patients and families cope with cancer and its treatment from pre‑diagnosis through treatment, survivorship, or end of life, with the goals of reducing symptom burden, preventing and treating complications, and preserving quality of life and ability to receive optimal anticancer therapy. [1][2][3][4] Major guidelines (ASCO, EORTC, ESMO, NCCN and national bodies) recommend a structured supportive care program that includes prophylactic and therapeutic use of G‑CSF for high‑ and selected intermediate‑risk chemotherapy regimens, antiemetic prophylaxis, pain and symptom management, nutritional and psychosocial support, and palliative care integration. Supportive care is considered an essential, standard part of comprehensive cancer management but is not viewed as a substitute for disease‑directed therapies; its medically accepted role is to support patients through treatment, reduce toxicity, and improve quality of life and sometimes enable more effective dosing of anticancer regimens.
“Cancer Support”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmune Conditions.
Autoimmune Conditions
- Supports
- The only indexed paper directly relevant to the influencer’s very general claim about autoimmune conditions is the systematic review and meta-analysis on autoimmune disorders in oral lichen planus. [11] Those reviewer reports relate to a published meta-analysis showing comorbidity between oral lichen planus (OLP) and autoimmune thyroid disease and diabetes mellitus. This supports the more general concept that specific autoimmune conditions tend to cluster and co-occur in the same individual, because OLP patients show increased rates of other autoimmune diseases. [14] High‑quality recent reviews and background chapters from academic search further support that autoimmune diseases are a broad class of disorders characterized by immune responses directed against self-antigens, involving breakdown of immune tolerance and multifactorial genetic and environmental risk factors, consistent with standard immunology and rheumatology texts and NIH overviews. Large epidemiologic reviews and consensus articles also support that the overall prevalence of autoimmune diseases is rising globally, and that autoantibodies can precede clinical disease by years, again aligning with the general medical concept of autoimmune conditions as chronic, progressive illnesses. [13] Guidelines and major reviews further support that autoimmune diseases often share pathophysiologic mechanisms (e. g. , Th17 skewing, regulatory T‑cell dysfunction, inflammasome activation), and that many patients are at increased risk for additional autoimmune diseases or related complications such as cardiovascular disease and certain cancers. Overall, the indexed systematic review on OLP plus mainstream reviews from academic search support the broad notion that autoimmune conditions are real, biologically grounded entities, frequently comorbid, and associated with chronic morbidity.
- Contradicts
- The provided index papers are largely not directly about broad influencer‑style claims on autoimmune conditions; most are specific clinical trials (e. g. , DNA sequencing in practice, perioperative analgesia, platelet‑rich fibrin, cryptosporidiosis treatment) that do not address autoimmune pathogenesis, diagnosis, or treatment, and therefore cannot be used to substantiate sweeping claims about autoimmune conditions. [14] The reviewer reports for the oral lichen planus meta-analysis themselves highlight that, beyond autoimmune thyroid disease and type 1 diabetes, evidence linking OLP to other autoimmune disorders (fibromyalgia, rheumatic diseases, Sjögren’s, lupus, dermatologic diseases, gastrointestinal autoimmune disorders) is weak, inconsistent, or in need of better-quality studies, indicating limits to how far comorbidity claims can be generalized. [11][13] Broader academic reviews emphasize that although autoimmune diseases share certain immune mechanisms, they are heterogeneous conditions and not a single entity with a unified cause or simple cure; this contradicts common influencer narratives that treat “autoimmunity” as one monolithic syndrome that can be reversed with single lifestyle or supplement interventions. [12] Major reviews also note that, despite progress in targeted therapies and immunomodulatory approaches, many autoimmune diseases still lack curative treatments and require long-term management, again countering simplistic cure claims. Because the influencer’s actual claim is unspecified and only labeled as “Autoimmune conditions,” there is no high‑quality evidence in the indexed papers that would support any strong, nonstandard assertion (e. g. , that most chronic symptoms are unrecognized autoimmunity or that autoimmunity can generally be cured quickly).
- Mainstream view
- Mainstream medical and scientific consensus views autoimmune conditions as a diverse group of diseases in which the immune system mounts pathogenic responses against self-tissues, driven by a combination of genetic susceptibility, environmental triggers, and dysregulated immune tolerance. [14] Autoimmune diseases are defined and classified based on reproducible clinical criteria, characteristic autoantibodies or cellular immune findings, and often supported by animal models and mechanistic data. They are common, with increasing incidence and prevalence documented in large epidemiologic studies, and they frequently co-occur; patients with one autoimmune disease have a higher-than-expected risk of developing additional autoimmune disorders, as illustrated by the comorbidity between oral lichen planus and autoimmune thyroid disease and type 1 diabetes. [11][12][13] At the same time, mainstream medicine recognizes substantial heterogeneity: different autoimmune diseases affect distinct organs, have varied clinical courses (from mild to life‑threatening), and respond differently to treatments. Standard of care focuses on accurate diagnosis, risk stratification, and long‑term management using immunosuppressive and immunomodulatory therapies, biologics, and, increasingly, targeted molecular agents, aiming for disease Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune Conditions”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS (Chronic Inflammatory Response Syndrome).
CIRS (Chronic Inflammatory Response Syndrome)
- Supports
- The indexed chapters and review papers describe Chronic Inflammatory Response Syndrome (CIRS) as a distinct clinical entity characterized by a chronic, multi‑system inflammatory illness following exposure to biotoxins such as those from water‑damaged buildings, certain infections, or marine toxins. [15] These sources present biological plausibility via innate immune dysregulation, complement activation, cytokine imbalances, neuroendocrine changes, and metabolic abnormalities, arguing that CIRS represents a specific pattern of chronic inflammatory response rather than nonspecific “mold illness”. A narrative review of diagnosis and mechanisms highlights proposed diagnostic criteria (documented biotoxin exposure, multi‑system illness, abnormal biomarkers such as C4a, TGF‑β1, MMP‑9, MSH, VIP, and response to treatment) and suggests that a growing body of clinical and mechanistic work supports the framework in selected cohorts. Research on ciguatoxin‑induced CIRS has identified distinct whole‑blood transcriptomic signatures separating affected patients from controls, supporting the existence of a reproducible immune and gene‑expression phenotype in at least one biotoxin‑linked chronic inflammatory syndrome labeled CIRS. Reviews comparing CIRS to myalgic encephalomyelitis/chronic fatigue syndrome describe layered biomarker development (visual contrast sensitivity, neuroendocrine markers, immunologic and transcriptomic signatures) and argue that CIRS can be differentiated from other fatiguing illnesses by exposure‑linked mechanisms and integrated biomarker profiles. Case reports and open‑label trials (e. g. , VIP nasal spray, hyperbaric oxygen therapy) and treatment reviews claim that protocol‑driven therapy (often based on Shoemaker’s biotoxin pathway model) can improve symptoms and normalize abnormal inflammatory and neuroendocrine markers in selected patients, lending some clinical support within this niche literature.
- Contradicts
- The available indexed evidence is largely composed of narrative reviews, case series, open‑label trials, and mechanistic or biomarker studies rather than large, independent randomized controlled trials or widely endorsed clinical guidelines, which weakens the strength of evidence for CIRS as a validated, universally accepted syndrome. [15] The major review of diagnosis and mechanisms explicitly acknowledges that CIRS is an “emerging and controversial” condition, with complex symptomatology, lack of standardized diagnostic criteria across institutions, and limited recognition in mainstream medicine, emphasizing that more rigorous research and consensus are needed. The concept and case definitions derive heavily from a single group of clinicians and researchers (e. g. , Shoemaker and collaborators), raising concerns about reproducibility and potential bias, especially given the reliance on proprietary diagnostic algorithms and treatment protocols. There is no indication in the indexed sources that major national or international bodies (such as large specialty societies or governmental guideline panels) have formally recognized CIRS as a distinct disease entity with standardized diagnostic and management guidelines, which contrasts with influencer claims that may portray CIRS as an established, mainstream diagnosis. The biomarker and transcriptomic studies show associations and patterns but do not definitively prove that these changes are unique to CIRS or that targeting them via specific protocols improves long‑term outcomes in controlled, comparative trials. Overall, the evidence base is preliminary and concentrated in a small research community; it does not yet reach the level of robust, widely replicated RCTs and high‑level guidelines that would fully substantiate strong clinical claims about CIRS for broad populations.
- Mainstream view
- Mainstream academic and clinical medicine currently regards Chronic Inflammatory Response Syndrome as a contested, incompletely validated diagnostic construct rather than a fully established, universally accepted disease category. [15] Conventional practice acknowledges that chronic symptoms after environmental or infectious exposures and chronic inflammation are real clinical problems, but most clinicians still evaluate such patients within existing, better‑defined frameworks (e. g. , allergy, asthma, chronic rhinosinusitis, autoimmune disease, chronic infections, and recognized conditions like ME/CFS), not under a separate CIRS label. The niche CIRS literature sees it as a coherent, biologically grounded entity with specific biomarker patterns and treatment protocols, yet mainstream medicine views these propositions as hypothesis‑generating and requiring larger, independent studies, standardized criteria, and external validation before broad
“CIRS (Chronic Inflammatory Response Syndrome)”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Leaky Gut & Digestive Disorders.
Leaky Gut & Digestive Disorders
- Supports
- The influencer’s broad phrase “leaky gut & digestive disorders” is vague, but there is evidence that objectively measured increased intestinal permeability (“leaky gut”) is present in some digestive disorders (especially IBS subtypes and IBD) and that targeted interventions can modulate this permeability and symptoms in specific, well-defined patient groups. Multiple clinical studies show that intestinal permeability is measurably abnormal in some patients with diarrhea-predominant IBS and ulcerative colitis, as well as in inflammatory bowel disease more broadly, supporting a connection between barrier dysfunction and certain digestive disorders.[20] Several randomized controlled trials and mechanistic reviews document that interventions can improve laboratory markers of intestinal permeability together with symptoms in specific conditions. Glutamine has been shown in a randomized trial to reduce lactulose:mannitol ratios (an in vivo permeability marker) and improve IBS symptom scores and stool characteristics in postinfectious IBS-D, and a recent review concludes that glutamine is the only nutritional supplement with consistent RCT evidence of improving leaky gut in the context of IBS and IBD.[20] A randomized pilot trial in healthy volunteers found that lubiprostone reduced NSAID-induced increases in lactulose–mannitol ratio compared with untreated controls, suggesting it can protect or restore intestinal barrier function under specific injurious conditions.[18] The MaPLE randomized controlled trial in older adults demonstrated that a polyphenol-rich dietary pattern reduced serum zonulin (a putative permeability biomarker) and other inflammatory markers, interpreted as an improvement in intestinal permeability in individuals with increased baseline leakiness.[19][21] Additional RCTs in IBS populations show that combinations such as multistrain probiotics plus vitamin D, Spirulina supplementation, and SCFA-producing probiotic regimens can reduce zonulin or lactulose:mannitol ratios and improve IBS symptom severity and bowel habit, indicating that in some IBS subtypes barrier-targeted strategies are associated with symptom relief.[6][7][9][13][20] Collectively, these data support a limited but real association between objectively measured increased intestinal permeability and certain defined digestive disorders, and they show that permeability can sometimes be favorably modulated with specific therapies under research conditions.
- Contradicts
- Despite these findings, mainstream evidence does not support a generalized “leaky gut & digestive disorders” narrative as commonly presented by influencers. A recent comprehensive review explicitly labels “leaky gut syndrome” as having more fallacies than facts, emphasizing that while intestinal permeability changes are observed in some IBS and functional dyspepsia patients, large, rigorously characterized prospective studies are lacking, and the popular notion of leaky gut syndrome as a broad explanation for diverse digestive complaints is not evidence-based.[20] That same review stresses that the term should not be used clinically unless objective permeability testing is performed, and even then therapeutic implications remain uncertain.[20] Meta-analytic data on probiotic interventions in people with high intestinal permeability show no significant improvement in intestinal leakage overall, indicating that widely promoted probiotic strategies for “leaky gut” lack consistent efficacy.[12] Studies of IBS show heterogeneous permeability changes: some report increased small-intestinal or colonic permeability in certain IBS subtypes, whereas others find decreased or normal permeability compared with controls, undercutting the idea that “leaky gut” is a uniform hallmark of IBS or most digestive disorders.[14][16][10][20] In IBD, increased intestinal permeability is well documented, but expert reviews note that using permeability-modulating nutritional immune modulators as therapy remains investigational and not ready for routine clinical practice.[22] The available RCTs demonstrating improvements in permeability markers (e.g., zonulin, lactulose:mannitol ratio) often involve small sample sizes, short follow-up, surrogate biomarkers with debated specificity (especially zonulin), and limited linkage to long-term clinical outcomes, meaning that these data do not validate broad claims that fixing “leaky gut” is a proven treatment for general digestive disorders.[13][20] Overall, evidence contradicts oversimplified influencer claims that leaky gut is a primary cause of most digestive problems or that generic supplements and diets reliably “heal” leaky gut and thereby cure digestive disease.
- Mainstream view
- Mainstream medical and scientific positions recognize intestinal permeability as a measurable physiological parameter that can be altered in specific diseases (notably inflammatory bowel disease, some IBS subtypes, and conditions like NSAID-induced enteropathy), but they do not endorse “leaky gut syndrome” as a general diagnosis or a catch-all explanation for digestive disorders.[20][22] Clinicians and guideline authors consider increased intestinal permeability one of several pathophysiologic contributors—alongside immune activation, microbiota changes, motility disturbances, central nervous system factors, and psychosocial variables—rather than a singular root cause of digestive disease.[ Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Leaky Gut & Digestive Disorders”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Lyme Disease.
Lyme Disease
No specific health claims of theirs were cross-checked against the literature.
“Lyme Disease”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Mold Toxicity.
Mold Toxicity
No specific health claims of theirs were cross-checked against the literature.
“Mold Toxicity”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid Disorders.
Thyroid Disorders
No specific health claims of theirs were cross-checked against the literature.
“Thyroid Disorders”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Chronic Fatigue.
Chronic Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure We take a comprehensive, integrative approach to cancer care.
We take a comprehensive, integrative approach to cancer care
No specific health claims of theirs were cross-checked against the literature.
“We take a comprehensive, integrative approach to cancer care”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Functional labs can uncover… Insulin resistance ... Hormonal imbalances.
Functional labs can uncover… Insulin resistance ... Hormonal imbalances
No specific health claims of theirs were cross-checked against the literature.
“Functional labs can uncover… Insulin resistance ... Hormonal imbalances”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS.
CIRS
- Supports
- The indexed chapters and review papers describe Chronic Inflammatory Response Syndrome (CIRS) as a distinct clinical entity characterized by a chronic, multi‑system inflammatory illness following exposure to biotoxins such as those from water‑damaged buildings, certain infections, or marine toxins. [15] These sources present biological plausibility via innate immune dysregulation, complement activation, cytokine imbalances, neuroendocrine changes, and metabolic abnormalities, arguing that CIRS represents a specific pattern of chronic inflammatory response rather than nonspecific “mold illness”. A narrative review of diagnosis and mechanisms highlights proposed diagnostic criteria (documented biotoxin exposure, multi‑system illness, abnormal biomarkers such as C4a, TGF‑β1, MMP‑9, MSH, VIP, and response to treatment) and suggests that a growing body of clinical and mechanistic work supports the framework in selected cohorts. Research on ciguatoxin‑induced CIRS has identified distinct whole‑blood transcriptomic signatures separating affected patients from controls, supporting the existence of a reproducible immune and gene‑expression phenotype in at least one biotoxin‑linked chronic inflammatory syndrome labeled CIRS. Reviews comparing CIRS to myalgic encephalomyelitis/chronic fatigue syndrome describe layered biomarker development (visual contrast sensitivity, neuroendocrine markers, immunologic and transcriptomic signatures) and argue that CIRS can be differentiated from other fatiguing illnesses by exposure‑linked mechanisms and integrated biomarker profiles. Case reports and open‑label trials (e. g. , VIP nasal spray, hyperbaric oxygen therapy) and treatment reviews claim that protocol‑driven therapy (often based on Shoemaker’s biotoxin pathway model) can improve symptoms and normalize abnormal inflammatory and neuroendocrine markers in selected patients, lending some clinical support within this niche literature.
- Contradicts
- The available indexed evidence is largely composed of narrative reviews, case series, open‑label trials, and mechanistic or biomarker studies rather than large, independent randomized controlled trials or widely endorsed clinical guidelines, which weakens the strength of evidence for CIRS as a validated, universally accepted syndrome. [15] The major review of diagnosis and mechanisms explicitly acknowledges that CIRS is an “emerging and controversial” condition, with complex symptomatology, lack of standardized diagnostic criteria across institutions, and limited recognition in mainstream medicine, emphasizing that more rigorous research and consensus are needed. The concept and case definitions derive heavily from a single group of clinicians and researchers (e. g. , Shoemaker and collaborators), raising concerns about reproducibility and potential bias, especially given the reliance on proprietary diagnostic algorithms and treatment protocols. There is no indication in the indexed sources that major national or international bodies (such as large specialty societies or governmental guideline panels) have formally recognized CIRS as a distinct disease entity with standardized diagnostic and management guidelines, which contrasts with influencer claims that may portray CIRS as an established, mainstream diagnosis. The biomarker and transcriptomic studies show associations and patterns but do not definitively prove that these changes are unique to CIRS or that targeting them via specific protocols improves long‑term outcomes in controlled, comparative trials. Overall, the evidence base is preliminary and concentrated in a small research community; it does not yet reach the level of robust, widely replicated RCTs and high‑level guidelines that would fully substantiate strong clinical claims about CIRS for broad populations.
- Mainstream view
- Mainstream academic and clinical medicine currently regards Chronic Inflammatory Response Syndrome as a contested, incompletely validated diagnostic construct rather than a fully established, universally accepted disease category. [15] Conventional practice acknowledges that chronic symptoms after environmental or infectious exposures and chronic inflammation are real clinical problems, but most clinicians still evaluate such patients within existing, better‑defined frameworks (e. g. , allergy, asthma, chronic rhinosinusitis, autoimmune disease, chronic infections, and recognized conditions like ME/CFS), not under a separate CIRS label. The niche CIRS literature sees it as a coherent, biologically grounded entity with specific biomarker patterns and treatment protocols, yet mainstream medicine views these propositions as hypothesis‑generating and requiring larger, independent studies, standardized criteria, and external validation before broad
“CIRS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Innovations in Cancer Care.
Innovations in Cancer Care
No specific health claims of theirs were cross-checked against the literature.
“Innovations in Cancer Care”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Intestinal permeability (leaky gut).
Intestinal permeability (leaky gut)
No specific health claims of theirs were cross-checked against the literature.
“Intestinal permeability (leaky gut)”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Blood sugar regulation and insulin resistance.
Blood sugar regulation and insulin resistance
No specific health claims of theirs were cross-checked against the literature.
“Blood sugar regulation and insulin resistance”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Insulin resistance.
Insulin resistance
No specific health claims of theirs were cross-checked against the literature.
“Insulin resistance”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Hormonal imbalances (thyroid, cortisol, sex hormones).
Hormonal imbalances (thyroid, cortisol, sex hormones)
No specific health claims of theirs were cross-checked against the literature.
“Hormonal imbalances (thyroid, cortisol, sex hormones)”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The Thyroid Example.
The Thyroid Example
No specific health claims of theirs were cross-checked against the literature.
“The Thyroid Example”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid peroxidase antibodies (TPOAb).
Thyroid peroxidase antibodies (TPOAb)
No specific health claims of theirs were cross-checked against the literature.
“Thyroid peroxidase antibodies (TPOAb)”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Detect autoimmune thyroid conditions.
Detect autoimmune thyroid conditions
No specific health claims of theirs were cross-checked against the literature.
“Detect autoimmune thyroid conditions”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Let’s look at autoimmune disease as an example as within their scope of practice.
Let’s look at autoimmune disease as an example
No specific health claims of theirs were cross-checked against the literature.
“Let’s look at autoimmune disease as an example”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure High Blood Pressure.
High Blood Pressure
No specific health claims of theirs were cross-checked against the literature.
“High Blood Pressure”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Heart Disease.
Heart Disease
No specific health claims of theirs were cross-checked against the literature.
“Heart Disease”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure High Cholesterol.
High Cholesterol
No specific health claims of theirs were cross-checked against the literature.
“High Cholesterol”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Celiac Disease.
Celiac Disease
No specific health claims of theirs were cross-checked against the literature.
“Celiac Disease”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
transcript · cited
The clinic presents cancer as one of the conditions it can address with its own protocols and testing, which can pull patients away from oncology-led care and toward a profit center built on fear and uncertainty. Likely motive: Convert a terrifying diagnosis into a clinic-generated treatment pipeline.
“Cancer Support”
transcript · cited
This frames extra testing as uniquely capable of finding the ‘real’ problem, which sets up repeat panels and follow-up visits even when standard evidence-based workups are the appropriate first step. Likely motive: Sell more labs by implying ordinary labs miss the truth.
“advanced, targeted lab testing reveals what’s actually happening beneath the surface”
transcript · cited
The page asserts special diagnostic insight and superior answers without showing validated methods or outcomes, borrowing the aura of science while skipping the burden of proof. Likely motive: Make the clinic sound uniquely expert so patients pay for the premium consult.
“This is where functional medicine stands apart.”
transcript · cited
The content links abnormal-looking functional labs to custom supplement protocols and in-clinic therapies, a classic funnel from worry to productized intervention. Likely motive: Turn results into recurring supplement and treatment sales.
“Based on your lab results, your care plan is tailored specifically to your needs and may include targeted nutrition strategies, supplement protocols designed to correct deficiencies”
transcript · cited
A long intake plus retesting plus personalized plans signals a high-ticket care funnel, especially when paired with advanced labs and ongoing protocol adjustments. Likely motive: Increase revenue per patient through lengthy evaluation and follow-up loops.
“A two-appointment, three- to six-hour new patient process”
Commerce & grift map
The likely money flow is scare-y chronic illness content -> advanced functional labs -> personalized protocol -> supplements and in-clinic add-ons like IVs, ozone, and red light. That is the classic root-cause funnel: the more confusing the condition, the more tests and products the clinic can sell, even when the evidence for the advertised disease model is weak or contested.
in2greatkc.com
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
in2greatkc.com
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
in2greatkc.com
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
in2greatkc.com
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Supplements pitched
- supplement protocols
“supplement protocols designed to correct deficiencies”
Labs pitched
- functional labs
“Advanced Lab Testing”
- advanced, targeted lab testing
“advanced, targeted lab testing reveals what’s actually happening beneath the surface”
How the money flows
- Lab testing referralUndisclosed The clinic markets advanced functional lab testing and retesting as a core service, creating a direct revenue stream from additional panels and follow-up interpretations. “Advanced Lab Testing”
“Advanced Lab Testing”
- Supplement brand dealUndisclosed The clinic sells supplement protocols tied to lab results, which commonly involve dispensary markup, practitioner sales, or affiliated supplement channels. “supplement protocols designed to correct deficiencies”
“supplement protocols designed to correct deficiencies”
- Coaching or consult upsellUndisclosed A lengthy two-appointment new-patient process and personalized protocol indicate a paid consultative care model rather than ordinary covered medicine. “A two-appointment, three- to six-hour new patient process”
“A two-appointment, three- to six-hour new patient process”
- Other financial tieUndisclosed The page promotes IV therapy, ozone/oxygen-based therapies, red light therapy, and regenerative medicine as purchasable add-ons. “IV Nutrition Therapy”
“IV Nutrition Therapy”
Store links detected
- Labs & TestingUnknown
- Lab ServicesUnknown
- Skip to contentUnknown
- unknownUnknown
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- in2greatkc.comBrand
Promoted commerce partner
- supplement protocolsBrand
Named on a surface without a compensation disclosure
- functional labsBrand
Named on a surface without a compensation disclosure
- advanced, targeted lab testingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor, Internist · KS license 01-05063.
Corey Priest presents as ‘Dr.’ while marketing broad functional-medicine care for systemic illness, but the provided content does not identify a physician license. The page repeatedly borrows doctor authority to promise root-cause diagnosis and treatment of internal diseases far beyond a narrow non-MD/DO scope if he is not a physician.
- Chiropractor (DC), Doctor of Chiropractic
Chiropractic scope is generally limited to evaluation and treatment of musculoskeletal and nervous-system conditions through spinal adjustment and authorized adjunctive therapies, not general internal medicine, prescription pharmacology, or primary disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: medium
Under Kansas law, chiropractors are licensed as practitioners of the healing arts and may diagnose and treat the human condition and its diseases, with primary statutory limits on prescribing medications, performing surgery, or obstetrics.[3] In practice this creates an unusually broad scope compared with most states, so chiropractors may evaluate and manage a wide range of systemic conditions as long as they do not prescribe drugs or perform surgery or obstetrics.[3] Any activity not involving prescribing legend drugs, surgery, or obstetrics is generally permitted within this broad diagnostic and treatment authority.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
24 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Cancer Support Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Autoimmune Conditions Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service CIRS (Chronic Inflammatory Response Syndrome) Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Leaky Gut & Digestive Disorders Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Lyme Disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Mold Toxicity Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Thyroid Disorders Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Chronic Fatigue Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| We take a comprehensive, integrative approach to cancer care Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Functional labs can uncover… Insulin resistance ... Hormonal imbalances Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service CIRS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Innovations in Cancer Care Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Intestinal permeability (leaky gut) Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Blood sugar regulation and insulin resistance Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Insulin resistance Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Hormonal imbalances (thyroid, cortisol, sex hormones) Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service The Thyroid Example Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Thyroid peroxidase antibodies (TPOAb) Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Detect autoimmune thyroid conditions Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Let’s look at autoimmune disease as an example Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service High Blood Pressure Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Heart Disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service High Cholesterol Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Celiac Disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
Sources: Kansas State Board of Healing Arts – main site (official), Kansas Chiropractic Association – description of Kansas chiropractic scope (official), Kansas (official), Kansas State Board of Healing Arts
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Overland Park, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-22 05:27 UTC. The archive pane loads styles and images from the intake snapshot.
13 licensed-care paths linked for out-of-scope claims.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (in2greatkc.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission WFcpaCJ28_KC8UNnue0US
Fight disinformation
Log a public thread where Corey M. Priest is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Corey M. Priest's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/WFcpaCJ28_KC8UNnue0US. White-coat charisma isn't evidence.
Full DTMB scan on Corey M. Priest: https://drtrustmebro.com/analyze/WFcpaCJ28_KC8UNnue0US
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Corey M. Priest can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Corey M. Priest, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Corey M. Priest. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: _FrDQl277A8SYiWclB5V-
- Wall entry: /influencer/_FrDQl277A8SYiWclB5V-
- Analysis ID: WFcpaCJ28_KC8UNnue0US
- Source: https://www.in2greatkc.com
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study
- [2] Effects of nature-based virtual reality interventions on physical and mental health symptoms in patients with cancer undergoing chemotherapy: a systematic review and meta-analysis protocol
- [3] Supportive therapies in the prevention of chemotherapy ... - PMC
- [4] PWSF2-7APPROPRIATE USE OF G-CSF IN CANCER TREATMENT: AN EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE-2013
- [5] PubMed indexed study
- [6] PubMed indexed study
- [7] PubMed indexed study
- [8] PubMed indexed study
- [9] PubMed indexed study
- [10] PubMed indexed study
- [11] Autoimmune disorders in oral lichen planus: A systematic review and ...
- [12] One year in autoimmunity - PubMed
- [13] The Increasing Prevalence of Autoimmunity and ... - PMC
- [14] Autoimmune Diseases: Molecular Pathogenesis and ... - PMC
- [15] Chronic inflammatory response syndrome: a review of ... - PMC
- [16] Eight weeks of resistance exercise improves mood state and intestinal permeability in healthy adults: A randomized controlled trial
- [17] The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome
- [18] The Leaky Gut: Mechanisms, Measurement and Clinical ...
- [19] Gastrointestinal permeability in patients with irritable bowel ... - PMC
- [20] Crosstalk among intestinal barrier, gut microbiota and ...
- [21] Intestinal Permeability In Vivo in Patients With Inflammatory Bowel ...
- [22] Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers
- [23] A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomised controlled trial